Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Talecris Biotherapeutics Announces Results of Annual Stockholders' Meeting

TALECRIS BIOTHERAPEUTICS
Posted on: 03 May 11

PR Newswire

RESEARCH TRIANGLE PARK, N.C., May 3, 2011

RESEARCH TRIANGLE PARK, N.C., May 3, 2011 /PRNewswire/ -- Talecris Biotherapeutics Holdings Corp. (NASDAQ: TLCR) held its annual meeting of stockholders today in Chapel Hill, N.C., where four proposals were submitted to, and approved by, stockholders.

Stockholders elected three directors to the company's Board of Directors to hold office for a three-year term until the annual meeting of stockholders in 2014, and until their successors are elected and qualified. The three directors are W. Brett Ingersoll, Lawrence D. Stern and Ruedi E. Waeger, PhD.

Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as the company's independent, registered, public accounting firm for the fiscal year ending December 31, 2011.

In a pair of advisory and non-binding votes, stockholders approved the compensation of the company's named executive officers and recommended holding an advisory vote every three years on compensation of the company's named executive officers.

A replay of the meeting will be available beginning at 1 p.m. EDT and will remain accessible until May 10, 2011, by dialing 1-888-286-8010 (domestic) or 1-617-801-6888 (international).  The pass code is 86974301. The webcast of the meeting call will be archived on the Investor Relations section of http://www.talecris.com.

About Talecris Biotherapeutics: Inspiration. Dedication. Innovation.

Talecris Biotherapeutics is a global biotherapeutic and biotechnology company that discovers, develops and produces critical care treatments for people with life-threatening disorders in a variety of therapeutic areas including immunology, pulmonology, neurology and hemostasis. For more information, please visit: www.talecris.com.

SOURCE Talecris Biotherapeutics Holdings Corp.

PR Newswire
http://www.prnewswire.com/

Last updated on: 03/05/2011

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.